큐리진

kor kor

큐리진 큐리진

kor kor

큐리진

korKOR engENG

기업소개

핵심기술

파이프라인

공지/뉴스

인재채용

기업소개

핵심기술

파이프라인

공지/뉴스

인재채용

Pipelines
  • Research
  • Production
  • Pre-clinical
  • Clinical trials

Candidate

  • Target validation
  • product optimization
  • POC
  • in vivo efficacy
  • Process development
  • GMP production
  • GLP-tox
  • IND
  • phase 1
CA102
  • {Viral Delivery}
  • Target Gene:
  • mTOR & STAT3

[Investigational Indications]

▪Bladder Cancer

CA106T
  • {Viral Delivery}
  • Target Genes:
  • MYC & BCL-2

[Investigational Indications]

▪Lung cancer

▪Ovarian cancer

CA103T
  • {Viral Delivery}
  • Target Gene:
  • mTOR & AR

[Investigational Indications]

▪Stage 4 Prostate Cancer

Cis102
  • {Viral Delivery}
  • Target Gene:
  • HBV & IL6

[Investigational Indications]

▪hepatitis B

Csi103
  • {Non-viral Delivery}
  • Target Genes:
  • PCSK9 & APOC

[Investigational Indications]

▪hyperlipidemia

Csi109
  • {Non-viral Delivery}
  • Target Genes:
  • ANO1 & MUC5AC

[Investigation Indications]

▪Cystic Fibrosis

CA102

GLP-tox

  • {Viral Delivery}
  • Target Gene:
  • mTOR & STAT3
  • [Investigational Indications]
  • ▪Bladder Cancer
CA106T

in vivo efficacy

  • {Viral Delivery}
  • Target Genes:
  • MYC & BCL-2
  • [Investigational Indications]
  • ▪Lung cancer
  • ▪Ovarian cancer
CA103T

POC

  • {Viral Delivery}
  • Target Gene:
  • mTOR & AR
  • [Investigational Indications]
  • ▪Stage 4 Prostate Cancer
Cis102

POC

  • {Viral Delivery}
  • Target Gene:
  • HBV & IL6
  • [Investigational Indications]
  • ▪hepatitis B
Csi103

POC

  • {Non-viral Delivery}
  • Target Genes:
  • PCSK9 & APOC
  • [Investigational Indications]
  • ▪hyperlipidemia
Csi109

POC

  • {Non-viral Delivery}
  • Target Genes:
  • ANO1 & MUC5AC
  • [Investigation Indications]
  • ▪Cystic Fibrosis